CASE Op-ed – Issues & Insights: Note To Congress: Do Not Try To Rescue The Solar Industry
Matthew Kandrach – President, CASE May 27, 2020 The country is experiencing the worst economic shock since the Great Depression,...
Matthew Kandrach – President, CASE May 27, 2020 The country is experiencing the worst economic shock since the Great Depression,...
Gerard Scimeca – Chairman, CASE May 26, 2020 The global plunge in oil prices, instigated by Russia and Saudi Arabia,...
Matthew Kandrach – President, CASE May 26 2020 In the wake of nearly 40 million jobless claims in recent weeks,...
Gerard Scimeca – Chairman, CASE May 15 2020 Washington continues to consider a wide variety of financial relief packages to help consumers...
Gerard Scimeca – Chairman, CASE April 23, 2020 An empty grocery shelf focuses the mind like nothing else. With COVID-19...
Gerard Scimeca – Chairman, CASE April 17, 2020 As the coronavirus pandemic lays siege to everyday life, mobile technology...
April 16, 2020 On January 21, 2020, the Centers for Disease Control and Prevention (CDC) confirmed the first case...
Gerard Scimeca – Chairman, CASE April 16, 2020 In news that should surprise absolutely nobody, America’s healthcare professionals have...
Gerard Scimeca – Chairman, CASE April 13, 2020 We are now past Day 100 since the arrival of the Covid-19...
Gerard Scimeca – Chairman, CASE April 10, 2020 Washington acted swiftly in passing the $2.2 trillion economic relief package to help...
.@POTUS’ IRA is driving up Part D premiums for millions of Medicare beneficiaries, yet Dems like @SenSanders continue to help tout this disastrous legislation. The Biden-Harris @WhiteHouse is misleading the public on their policy’s real impact.
Two weeks from election day, the supposedly independent @FCC is proposing price regulation of #broadband by restricting what data plans companies can offer.
By prohibiting usage-based plans, the FCC would end up increasing prices FOR EVERYONE, including low-data users!
CASE Letter Urges FDA & FTC to Scrutinize Deal Between L’Oréal and Galderma -- "Both companies are currently under investigation or facing sizable lawsuits from claims that they have used harmful chemicals in their products."
https://caseforconsumers.org/2024/10/21/case-letter-urges-fda-ftc-to-scrutinize-deal-between-loreal-and-galderma/
© 2024 · Case for Consumers